{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T18:13:39Z","timestamp":1788632019628,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:00:00Z","timestamp":1788566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:00:00Z","timestamp":1788566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["DARU J Pharm Sci"],"DOI":"10.1007\/s40199-026-00656-4","type":"journal-article","created":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T06:07:31Z","timestamp":1788588451000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["TPGS-stabilized pyrimethamine micelles promote ROS-associated apoptosis in MDA-MB-231 cells and suppress tumour progression in a murine lymphoma model"],"prefix":"10.1007","volume":"34","author":[{"given":"Indrajeet","family":"Yadav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0533-2696","authenticated-orcid":false,"given":"Manisha","family":"Nidhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavan","family":"Goud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surya Nath","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish Kumar","family":"Tewari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3170-8648","authenticated-orcid":false,"given":"Priyanka","family":"Sonker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,5]]},"reference":[{"key":"656_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc706","author":"MM Gottesman","year":"2002","unstructured":"Gottesman MM, et al. Mechanisms of cancer drug resistance. Nat Rev Cancer. 2002. https:\/\/doi.org\/10.1038\/nrc706.","journal-title":"Nat Rev Cancer"},{"key":"656_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3599","author":"C Holohan","year":"2013","unstructured":"Holohan C, et al. Cancer drug resistance: an evolving paradigm. Nat Rev Cancer. 2013. https:\/\/doi.org\/10.1038\/nrc3599.","journal-title":"Nat Rev Cancer"},{"key":"656_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/path.1701","author":"DB Longley","year":"2005","unstructured":"Longley DB, Johnston PG, et al. Molecular mechanisms of drug resistance. J Pathol. 2005. https:\/\/doi.org\/10.1002\/path.1701.","journal-title":"J Pathol"},{"key":"656_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-007-9067-6","author":"YG Assaraf","year":"2007","unstructured":"Assaraf YG, et al. Molecular basis of antifolate resistance. Cancer Metastasis Rev. 2007. https:\/\/doi.org\/10.1007\/s10555-007-9067-6.","journal-title":"Cancer Metastasis Rev"},{"key":"656_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1984","author":"G Szak\u00e1cs","year":"2006","unstructured":"Szak\u00e1cs G, et al. Targeting multidrug resistance in cancer. Nat Rev Drug Discov. 2006. https:\/\/doi.org\/10.1038\/nrd1984.","journal-title":"Nat Rev Drug Discov"},{"key":"656_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2803","author":"D Trachootham","year":"2009","unstructured":"Trachootham D, et al. Targeting cancer cells by ROS-mediated mechanisms. Nat Rev Drug Discov. 2009. https:\/\/doi.org\/10.1038\/nrd2803.","journal-title":"Nat Rev Drug Discov"},{"key":"656_CR7","doi-asserted-by":"publisher","DOI":"10.1021\/jm061145p","author":"A Gangjee","year":"2007","unstructured":"Gangjee A, et al. DHFR inhibitors in cancer therapy. J Med Chem. 2007. https:\/\/doi.org\/10.1021\/jm061145p.","journal-title":"J Med Chem"},{"key":"656_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206948","author":"R Zhao","year":"2003","unstructured":"Zhao R, Goldman ID, et al. Resistance to antifolates. Oncogene. 2003. https:\/\/doi.org\/10.1038\/sj.onc.1206948.","journal-title":"Oncogene"},{"key":"656_CR9","doi-asserted-by":"publisher","DOI":"10.1126\/science.1160809","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden MG, et al. Understanding Warburg effect & metabolic stress. Science. 2009. https:\/\/doi.org\/10.1126\/science.1160809.","journal-title":"Science"},{"key":"656_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209608","author":"S Fulda","year":"2006","unstructured":"Fulda S, Debatin KM, et al. Intrinsic apoptosis pathway. Oncogene. 2006. https:\/\/doi.org\/10.1038\/sj.onc.1209608.","journal-title":"Oncogene"},{"key":"656_CR11","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.cej.2025.163795","volume":"520","author":"X Wenhui Wang","year":"2025","unstructured":"Wenhui Wang X, Zeng, et al. A polymer-based immunogenic cell death amplifier promotes systemic breast cancer inhibition through combined mitochondrial oxidative stress and calcium overload. Chem Eng J. 2025;520:1385\u20138947. https:\/\/doi.org\/10.1016\/j.cej.2025.163795.","journal-title":"Chem Eng J"},{"key":"656_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-024-48742-y","volume":"15","author":"SF Razavipour","year":"2024","unstructured":"Razavipour SF, Yoon H, et al. C-terminally phosphorylated p27 activates self-renewal driver genes to program cancer stem cell expansion, mammary hyperplasia and cancer. Nat Commun. 2024;15:1\u201318. https:\/\/doi.org\/10.1038\/s41467-024-48742-y.","journal-title":"Nat Commun"},{"key":"656_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biomaterials.2015.06.005","volume":"63","author":"SL Chia","year":"2015","unstructured":"Chia SL, Setyawati MI, et al. In vivo and ex vivo proofs of concept that cetuximab-conjugated vitamin E TPGS micelles increase efficacy of delivered docetaxel against triple-negative breast cancer. Biomaterials. 2015;63:1\u201317. https:\/\/doi.org\/10.1016\/j.biomaterials.2015.06.005.","journal-title":"Biomaterials"},{"key":"656_CR14","doi-asserted-by":"publisher","DOI":"10.1021\/mp060107p","author":"EM Collnot","year":"2007","unstructured":"Collnot EM, et al. TPGS inhibits P-gp. Mol Pharm. 2007. https:\/\/doi.org\/10.1021\/mp060107p.","journal-title":"Mol Pharm"},{"issue":"1","key":"656_CR15","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1080\/10717544.2017.1406561","volume":"24","author":"S Tan","year":"2017","unstructured":"Tan S, Zou C, Zhang W, et al. Recent developments in d-\u03b1-tocopheryl polyethylene glycol-succinate-based nanomedicine for cancer therapy. Drug Deliv. 2017;24(1):1831\u201342. https:\/\/doi.org\/10.1080\/10717544.2017.1406561.","journal-title":"Drug Deliv"},{"issue":"23","key":"656_CR16","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.4155\/fmc-2022-0199","volume":"14","author":"P Sonker","year":"2022","unstructured":"Sonker P, Singh M, et al. pyrimido-pyridazine derivatives: design, synthesis, anticancer evaluation and in silico studies. Future Med Chem. 2022;14(23):1693\u2013704. https:\/\/doi.org\/10.4155\/fmc-2022-0199.","journal-title":"Future Med Chem"},{"key":"656_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.120937","volume":"308","author":"M Singh","year":"2022","unstructured":"Singh M, Singh V, et al. TPGS loaded triphenyltin (IV) micelles induced apoptosis by upregulating p53 in breast cancer cells and inhibit tumor progression in T-cell lymphoma bearing mice. Life Sci. 2022;308:120937. https:\/\/doi.org\/10.1016\/j.lfs.2022.120937.","journal-title":"Life Sci"},{"key":"656_CR18","doi-asserted-by":"publisher","first-page":"108677","DOI":"10.1016\/j.bioorg.2026.108677","volume":"158","author":"R Priyanka Sonker","year":"2026","unstructured":"Priyanka Sonker R, Tamang, et al. Design, synthesis, in silico, in vitro and in vivo anticancer potential of sulphonamide-ethylamine-triazole-aryl in against triple negative breast cancer and Dalton lymphoma. Bioorg Chem. 2026;158:108677. https:\/\/doi.org\/10.1016\/j.bioorg.2026.108677.","journal-title":"Bioorg Chem"},{"issue":"1","key":"656_CR19","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1021\/acsbiomaterials.5c01386","volume":"12","author":"NV Randhave","year":"2026","unstructured":"Randhave NV, et al. Glycogen-linked TPGS nanomicelles for hypoxia-responsive PD-L1 targeting and molecular imaging of breast tumor. ACS Biomater Sci Eng. 2026;12(1):365\u201384. https:\/\/doi.org\/10.1021\/acsbiomaterials.5c01386.","journal-title":"ACS Biomater Sci Eng"},{"issue":"1","key":"656_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11095-006-9132-0","volume":"24","author":"VP Torchilin","year":"2007","unstructured":"Torchilin VP. Micellar nanocarriers: pharmaceutical perspectives. Pharm Res. 2007;24(1):1\u201316. https:\/\/doi.org\/10.1007\/s11095-006-9132-0.","journal-title":"Pharm Res"},{"issue":"40","key":"656_CR21","doi-asserted-by":"publisher","first-page":"41830","DOI":"10.1021\/acsomega.4c06264","volume":"9","author":"Raisuddin Ali","year":"2024","unstructured":"Raisuddin Ali, Wajhul Qamar, et al. Soloplus: TPGS Mixed Micelles as a Delivery System for Brigatinib: Characterization and In Vitro Evaluation. ACS Omega. 2024;9(40):41830\u201340. https:\/\/doi.org\/10.1021\/acsomega.4c06264.","journal-title":"ACS Omega"},{"key":"656_CR22","doi-asserted-by":"publisher","unstructured":"Bhushan B, Berlin et al. Heidelberg: Springer. 2006. https:\/\/doi.org\/10.1007\/978-3-540-37316-2.","DOI":"10.1007\/978-3-540-37316-2"},{"issue":"1","key":"656_CR23","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0169-409X(00)00124-1","volume":"47","author":"K Kataoka","year":"2001","unstructured":"Kataoka K, Harada A, Nagasaki Y. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Deliv Rev. 2001;47(1):113\u201331. https:\/\/doi.org\/10.1016\/S0169-409X(00)00124-1.","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"656_CR24","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3390\/nano15040265","volume":"10","author":"S Alfei","year":"2025","unstructured":"Alfei S, Zuccari G, et al. Last Fifteen Years of Nanotechnology Application with Our Contribute. Nanomaterials (Basel). 2025;10(4):265.","journal-title":"Nanomaterials (Basel)"},{"key":"656_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mtcomm.2022.103256","volume":"31","author":"M Singh","year":"2022","unstructured":"Singh M, et al. Enhanced in vitro therapeutic efficacy of triphenyltin (IV) loaded vitamin E TPGS against breast cancer therapy. Mater Today Commun. 2022;31:1\u201317. https:\/\/doi.org\/10.1016\/j.mtcomm.2022.103256.","journal-title":"Mater Today Commun"},{"issue":"10","key":"656_CR26","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.addr.2009.04.016","volume":"61","author":"Y Bae","year":"2009","unstructured":"Bae Y, Kataoka K. Intelligent polymeric micelles from functional poly (ethylene glycol)-poly (amino acid) block copolymers. Adv Drug Deliv Rev. 2009;61(10):768\u201384. https:\/\/doi.org\/10.1016\/j.addr.2009.04.016.","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"656_CR27","doi-asserted-by":"publisher","first-page":"5290","DOI":"10.1021\/acsami.4c16800","volume":"17","author":"S He","year":"2025","unstructured":"He S, Baron A, Musuc AM, et al. Drug release nanoparticle system design: data set compilation and machine learning modeling. ACS Appl Mater Interfaces. 2025;17(3):5290\u2013306.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"8","key":"656_CR28","doi-asserted-by":"publisher","first-page":"751","DOI":"10.4155\/fmc-2023-0344","volume":"16","author":"P Sonker","year":"2024","unstructured":"Sonker P, Tamang R, et al. PTSA-induced synthesis, in silico and nano study of novel ethylquinolin-thiazolo-triazole in cervical cancer. Future Med Chem. 2024;16(8):751\u201367. https:\/\/doi.org\/10.4155\/fmc-2023-0344.","journal-title":"Future Med Chem"},{"issue":"4","key":"656_CR29","doi-asserted-by":"publisher","first-page":"e0120129","DOI":"10.1371\/journal.pone.0120129","volume":"10","author":"Z Fan","year":"2015","unstructured":"Fan Z, Chen C, Pang X, et al. Adding vitamin E-TPGS to the formulation of Genexol-PM: specially mixed micelles improve drug-loading ability and cytotoxicity against multidrug-resistant tumors significantly. PLoS ONE. 2015;10(4):e0120129. https:\/\/doi.org\/10.1371\/journal.pone.0120129.","journal-title":"PLoS ONE"},{"issue":"1","key":"656_CR30","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s43141-023-00529-2","volume":"21","author":"SA Ahmed","year":"2023","unstructured":"Ahmed SA, Al-Shanon AF, et al. Antiproliferative and cell cycle arrest potentials of 3-O-acetyl-11-keto-\u03b2-boswellic acid against MCF-7 cells in vitro. J Genet Eng Biotechnol. 2023;21(1):75. https:\/\/doi.org\/10.1186\/s43141-023-00529-2.","journal-title":"J Genet Eng Biotechnol"},{"issue":"5","key":"656_CR31","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1023\/a:1009616228304","volume":"5","author":"HU Simon","year":"2000","unstructured":"Simon HU, Haj-Yehia A, Levi-Schaffer F, et al. Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis. 2000;5(5):415\u20138. https:\/\/doi.org\/10.1023\/a:1009616228304.","journal-title":"Apoptosis"},{"key":"656_CR32","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/978-1-4419-6199-0_9","volume":"676","author":"Z Darzynkiewicz","year":"2010","unstructured":"Darzynkiewicz Z, Halicka HD, et al. Analysis of cellular DNA content by flow and laser scanning cytometry. Adv Exp Med Biol. 2010;676:137\u201347. https:\/\/doi.org\/10.1007\/978-1-4419-6199-0_9.","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"656_CR33","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0022-1759(95)00072-i","volume":"17","author":"I Vermes","year":"1995","unstructured":"Vermes I, Haanen C, et al. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods. 1995;17(1):39\u201351. https:\/\/doi.org\/10.1016\/0022-1759(95)00072-i.","journal-title":"J Immunol Methods"},{"issue":"11","key":"656_CR34","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1038\/sj.bjc.6605642","volume":"102","author":"P Workman","year":"2010","unstructured":"Workman P, Aboagye EO, Committee of the National Cancer Research Institute, et al. Guidelines for the welfare and use of animals in cancer research. Br J Cancer. 2010;102(11):1555\u201377. https:\/\/doi.org\/10.1038\/sj.bjc.6605642.","journal-title":"Br J Cancer"},{"key":"656_CR35","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.2147\/IJN.S352538","volume":"17","author":"R Zuo","year":"2022","unstructured":"Zuo R, Zhang Y, Chen X, et al. Orally administered halofuginone-loaded TPGS polymeric micelles against triple-negative breast cancer: enhanced absorption and efficacy with reduced toxicity and metastasis. Int J Nanomedicine. 2022;17:2475\u201391. https:\/\/doi.org\/10.2147\/IJN.S352538.","journal-title":"Int J Nanomedicine"},{"issue":"4","key":"656_CR36","doi-asserted-by":"publisher","first-page":"274","DOI":"10.4103\/0974-7788.76794","volume":"1","author":"MK Goel","year":"2010","unstructured":"Goel MK, Khanna P, Kishore J, et al. Understanding survival analysis: Kaplan-Meier estimate. Int J Ayurveda Res. 2010;1(4):274\u20138. https:\/\/doi.org\/10.4103\/0974-7788.76794.","journal-title":"Int J Ayurveda Res"}],"container-title":["DARU Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-026-00656-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40199-026-00656-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-026-00656-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T18:02:38Z","timestamp":1788631358000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40199-026-00656-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,5]]},"references-count":36,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["656"],"URL":"https:\/\/doi.org\/10.1007\/s40199-026-00656-4","relation":{},"ISSN":["2008-2231"],"issn-type":[{"value":"2008-2231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,5]]},"assertion":[{"value":"26 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"IAEC Approval Reference No. BHU\/DoZ\/IAEC\/2021-2022\/014 Date of IAEC meeting held : 15.02.2022 Project code number : IAEC\/2021-22\/14 Funding source & its status (Applied\/Approved) : UGC-BHU Fellowship Title of the research project : Synthesis of bioactive molecules and their antiproliferative efficacy in cancer cells. Name of the Principal Investigator and\/or other associated staff & Position : Dr. Biplob Koch, Associate Professor, Department of Zoology; Dr A K Tewari, Professor; Ms. Priyanka Sonker, Department of Chemistry, BHU Duration of the approved project : 3 Year IAEC approval status of the protocol : Approved Animal sp. \/strain\/age\/sex etc and numbers approved by the IAEC Year-wise: 1st year: Nil mice, 2nd year Nil mice, 3rd year 20 male & 20 female Swiss Albino BALb\/c mice (total 40 Swiss Albino BALb\/c mice) 1st year sanction: NIL Expiry period of IAEC approval :Three Years 1. Human-subjects accordance statement: \u201cNot applicable. This study did not involve human participants, human biological samples, or human-derived data. The study involved animals only.\u201d 2. Human research ethics approval statement: \u201cNot applicable. No human participants were involved in this study; therefore, human research ethics approval was not required.\u201d 3. Informed-consent statement: \u201cNot applicable. The study did not involve human participants; therefore, informed consent was not required.\u201d","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"69"}}